Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessing the human immune response to SARS-CoV-2 variants.

Literature DB >> 33649495

Assessing the human immune response to SARS-CoV-2 variants.

Roberto Burioni¹, Eric J Topol².

Abstract

Entities: Species

Year: 2021 PMID： 33649495 DOI： 10.1038/s41591-021-01290-0

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

1 in total

1. Risk of primary infection and reinfection with respiratory syncytial virus.

Authors: W P Glezen; L H Taber; A L Frank; J A Kasel
Journal: Am J Dis Child Date: 1986-06

1 in total

11 in total

1. VGsim: Scalable viral genealogy simulator for global pandemic.

Authors: Vladimir Shchur; Vadim Spirin; Dmitry Sirotkin; Evgeni Burovski; Nicola De Maio; Russell Corbett-Detig
Journal: PLoS Comput Biol Date: 2022-08-24 Impact factor: 4.779

Review 2. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.

Authors: Suhad Daher-Nashif; Rania Al-Anany; Menatalla Ali; Khadija Erradi; Elmoubasher Farag; Abdallah M Abdallah; Mohamed M Emara
Journal: Arch Virol Date: 2022-06-20 Impact factor: 2.685

Review 3. Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity.

Authors: Eman Alefishat; Herbert F Jelinek; Mira Mousa; Guan K Tay; Habiba S Alsafar
Journal: J Infect Public Health Date: 2022-01-13 Impact factor: 3.718

Review 4. Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications.

Authors: Aakriti Dubey; Shweta Choudhary; Pravindra Kumar; Shailly Tomar
Journal: Curr Microbiol Date: 2021-12-14 Impact factor: 2.188

5. MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants.

Authors: Sua Lee; Shina Jang; Jihoon Kang; Soo Bin Park; Young Woo Han; Hyemi Nam; Munkyung Kim; Jeewon Lee; Ki Joon Cho; Jeonghun Kim; Miyoung Oh; Jihye Ryu; Jong Hyeon Seok; Yunhwa Kim; Jee-Boong Lee; Man-Seong Park; Yong-Sung Kim; Hosun Park; Dong-Sik Kim
Journal: Front Immunol Date: 2021-11-18 Impact factor: 8.786

6. Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants.

Authors: Yi-Nan Zhang; Jennifer Paynter; Cindy Sou; Tatiana Fourfouris; Ying Wang; Ciril Abraham; Timothy Ngo; Yi Zhang; Linling He; Jiang Zhu
Journal: Sci Adv Date: 2021-10-20 Impact factor: 14.136

Assessing the human immune response to SARS-CoV-2 variants.

1. Risk of primary infection and reinfection with respiratory syncytial virus.

1. VGsim: Scalable viral genealogy simulator for global pandemic.

Review 2. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.

Review 3. Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity.

Review 4. Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications.

5. MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants.

6. Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants.

7. Both simulation and sequencing data reveal coinfections with multiple SARS-CoV-2 variants in the COVID-19 pandemic.

8. Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate.

9. Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro.

Review 10. Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic-Experience and Outlines.